Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Krishn SR"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
    Autorzy:
    Quaglia F; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Krishn SR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Sossey-Alaoui K; Department of Medicine, School of Medicine, MetroHealth Medical Center, Rammelkamp Center for Research, Case Western Reserve University, Cleveland, OH, USA.
    Rana PS; Department of Medicine, School of Medicine, MetroHealth Medical Center, Rammelkamp Center for Research, Case Western Reserve University, Cleveland, OH, USA.
    Pluskota E; Cardiovascular and Metabolic Sciences Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
    Park PH; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Shields CD; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Lin S; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    McCue P; Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
    Kossenkov AV; Center for Systems and Computational Biology, Wistar Institute, Philadelphia, PA, USA.
    Wang Y; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
    Goodrich DW; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
    Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
    Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
    Kelly WK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
    Corey E; Department of Urology, University of Washington, Seattle, WA, USA.
    Klose M; Institute of Neurochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
    Bandtlow C; Institute of Neurochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
    Liu Q; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
    Altieri DC; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
    Plow EF; Cardiovascular and Metabolic Sciences Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
    Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA. .; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Nov 07; Vol. 12 (1), pp. 18879. Date of Electronic Publication: 2022 Nov 07.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
    MeSH Terms:
    Carcinoma, Neuroendocrine*/pathology
    Prostatic Neoplasms*/pathology
    Nogo Receptor 2*/metabolism
    Animals ; Humans ; Male ; Mice ; Androgen Antagonists ; Cell Line, Tumor ; Integrins
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
    Autorzy:
    Quaglia F; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States of America.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Krishn SR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States of America.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Wang Y; Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America.
    Goodrich DW; Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America.
    McCue P; Department of Pathology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Kossenkov AV; Center for Systems and Computational Biology, Wistar Institute, Philadelphia, PA, United States of America.
    Mandigo AC; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Knudsen KE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Weinreb PH; Biogen Inc., Cambridge, MA, United States of America.
    Corey E; Department of Urology, University of Washington, Seattle, Washington, United States of America.
    Kelly WK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States of America.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 Jan 22; Vol. 16 (1), pp. e0244985. Date of Electronic Publication: 2021 Jan 22 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Gene Expression Regulation, Neoplastic*
    Adenocarcinoma/*metabolism
    Antigens, Neoplasm/*metabolism
    Integrin alphaVbeta3/*metabolism
    Integrins/*metabolism
    Prostate/*metabolism
    Prostatic Neoplasms/*metabolism
    Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Animals ; Cell Line, Tumor ; Disease Models, Animal ; Disease Progression ; Humans ; Male ; Mice ; Mice, Nude ; Mice, Transgenic ; Neoplasm Transplantation ; Prostate/pathology ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology ; Retinoblastoma Protein/genetics ; Synaptophysin/metabolism ; Tumor Suppressor Protein p53/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells.
    Autorzy:
    Quaglia F; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Krishn SR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Daaboul GG; Department of Research and Development, NanoView Biosciences, Boston, MA, USA.
    Sarker S; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Pippa R; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
    Domingo-Domenech J; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
    Kumar G; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Fortina P; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    McCue P; Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
    Kelly WK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
    Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
    Liu Q; Molecular and Cellular Oncogenesis Program, the Wistar Institute, Philadelphia, PA, USA.
    Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
    Pokaż więcej
    Źródło:
    Journal of extracellular vesicles [J Extracell Vesicles] 2020 May 24; Vol. 9 (1), pp. 1761072. Date of Electronic Publication: 2020 May 24.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The αvβ6 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis.
    Autorzy:
    Krishn SR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Salem I; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Quaglia F; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Naranjo NM; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Agarwal E; Prostate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, USA.; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, USA.
    Liu Q; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, USA.
    Sarker S; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Kopenhaver J; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    McCue PA; Department of Pathology, Thomas Jefferson University, Philadelphia, USA.
    Weinreb PH; Biogen Inc., Cambridge, USA.
    Violette SM; Biogen Inc., Cambridge, USA.; Admirx Tx, Cambridge.
    Altieri DC; Prostate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, USA.; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, USA.
    Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, USA.; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
    Pokaż więcej
    Źródło:
    Journal of extracellular vesicles [J Extracell Vesicles] 2020 May 20; Vol. 9 (1), pp. 1763594. Date of Electronic Publication: 2020 May 20 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer.
    Autorzy:
    Pothuraju R; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Krishn SR; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Gautam SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Pai P; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Ganguly K; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Chaudhary S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Rachagani S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Kaur S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Batra SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE-68105, USA.; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE-68198, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 Mar 11; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 11.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
    Autorzy:
    Pothuraju R; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Rachagani S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Krishn SR; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Chaudhary S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Nimmakayala RK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Siddiqui JA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Ganguly K; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Lakshmanan I; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Cox JL; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
    Mallya K; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Kaur S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
    Batra SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. .; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. .; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. .; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. .
    Pokaż więcej
    Źródło:
    Molecular cancer [Mol Cancer] 2020 Feb 25; Vol. 19 (1), pp. 37. Date of Electronic Publication: 2020 Feb 25.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Drug Resistance, Neoplasm*
    Antineoplastic Combined Chemotherapy Protocols/*pharmacology
    Biomarkers, Tumor/*metabolism
    Colorectal Neoplasms/*pathology
    Hyaluronan Receptors/*metabolism
    Mucin 5AC/*metabolism
    Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/metabolism ; Disease Progression ; Fluorouracil/administration & dosage ; Gene Expression Regulation, Neoplastic ; Humans ; Hyaluronan Receptors/genetics ; Mice ; Mice, Nude ; Mucin 5AC/genetics ; Oxaliplatin/administration & dosage ; Prognosis ; Survival Rate ; Tumor Cells, Cultured ; Wnt Signaling Pathway ; Xenograft Model Antitumor Assays ; beta Catenin/genetics ; beta Catenin/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies